Northway Biotech

Northway Biotech is a contract development and manufacturing organization (CDMO) specializing in biologics and gene therapy, serving customers worldwide. Its highly experienced and professional team manages projects at every stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise and vertically integrated service offerings enable the rapid execution of multiple projects from its state-of-the-art GMP facilities, ensuring full process and product compliance throughout research, development, and commercial manufacturing. Founded in 2004, Northway Biotech is a privately owned company with locations in Vilnius, Lithuania, London, United Kingdom, and Waltham, MA, USA.

Type of Drugs Manufactured:

Biologics;Cell & Gene Therapy

CDMO Services:

Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Aseptic Fill Finish;Research & Development;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

3-5

Facilities Locations:

Europe;North America

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);ISO;GMP

Manufacturing Technologies:

Cartridges;Liquids;Lyophilized amps/vials;Pre-Filled Syringes (PFS)